Pico-Tesla plans atrial fibrillation trial
This article was originally published in The Gray Sheet
Executive Summary
Pico-Tesla will begin a U.S. clinical trial of its Resonator electromagnetic field generator to treat paroxysmal atrial fibrillation in the fourth quarter, according to the company. Clinical trials are already ongoing for use of the device to create low-level electromagnetic fields (EMF) to treat Parkinson's disease and type-2 diabetes. In May, a dog study at the University of Oklahoma's Heart Rhythm Institute suggested EMF fields from the device can terminate and prevent atrial fibrillation. The so-called Magneceutical therapy system comprises two large magnetic coils; patients sit between the coils for treatment (1"The Gray Sheet" Nov. 9, 2009)